SAN FRANCISCO, June 8 /PRNewswire/ -- The Australian biotechnology company, CogState, has developed a computerized test of cognition and brain function based on playing cards. Initially developed for work with the aboriginal community of Australia, the card-based test is considered to be truly cross-cultural.
CogState (http://www.cogstate.com/) recently signed a deal with Pfizer to market tests for Alzheimer's Disease. The company's card-based test also was approved by the Australian Alzheimer's Association as a method to gather baseline data for people over 50, providing a way to detect any early signs of the disease so that intervention can start as soon as possible.
Like a thermometer for the brain, the test is used to test for brain injury in U.S. athletes, including American collegiate amateur boxers (as shown in a study to be discussed this week at the American College of Sports Medicine meeting in Indianapolis, Ind.) and also to determine effects of concussion in sports groups such as the U.S. Olympic Ski Team, the South African Rugby League team and the UK Jockey Club.
More information about the card-based, computerized testing of brain function and demonstrations of the test are available from CogState executives attending BIO 2004 this week.
Further information regarding Victoria, Australia's biotechnology initiatives is available on the web, at http://www.biotechnology.vic.gov.au/.
Government of Victoria, Australia
CONTACT: Dr. Peter Bick, CEO of CogState, 011-61-408-415-823, or+1-415-487-1770; or Tania Ewing, Media Consultant, 011-61-428-378-422, orWendy Lewis of FS Communications, +1-650-691-1488, or cell, +1-408-230-1060,both for Government of Victoria, Australia